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CHAPTER 1 
 
 
 
INTRODUCTION 
 
 
 
1.1 General Introduction 
 
Zingiberaceae family comprises of approximately 47 genera and about 1500 
species. Plants in this family are monocotyledon and grow naturally in tropical and 
sub-tropical forest in Asia, India and Australia [1]. 
 
Members of the Zingiberaceae family have been considered important as 
natural spices or as medicinal plants. The well-known examples of species used as 
spices are the rhizomes of Zingiber officinale (true ginger), Curcuma domestica 
(turmeric) and Phaeomeria sp. (kantan). Many other species have been used in 
traditional medicine including Kaempferia galanga (cekur), Z. zerumbet 
(lempoyang), Alpinia galanga (lengkuas) and C. xanthorrhiza (temu lawak).  
 
 
 
1.2 Curcuma xanthorrhiza 
 
Curcuma xanthorrhiza, locally known as temu lawak or shu gu jiang huang (
束骨薑黄) in Chinese is a zingiberaceous plant used medicinally in Southeast Asia. 
In Indonesia, its rhizome is widely used as a tonic and cholagogue. In Europe, it is 
employed in choleretic drug preparations. In Thailand, the rhizome of this plant is 
used by local people, especially in the eastern and northeastern parts of the country, 
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for the treatment of inflammation in postpartum uterine bleeding and also as an 
emmenagogue [2]. 
 
 
 
1.3 Chemical Constituents of Curcuma xanthorrhiza 
 
Chemical constituents of C. xanthorrhiza have been well-investigated and 
previous studies on this species have yielded an assortment of monoterpenoids, 
sesquiterpenoids and diarylheptanoids. 
 
The major constituent of C. xanthorrhiza is xanthorrhizol (1), a bisabolane-
type sesquiterpenoid which was first isolated from rhizomes of C. xanthorrhiza in 
1970 [3]. Xanthorrhizol (1) was also isolated from the root of Mexican medicinal 
plant, Iostephane heterophylla [4,5]. John et al. assigned the absolute configuration 
of (–)-xanthorrhizol (1) as R-configuration by the synthesis of (S)-(+)-xanthorrhizol 
from (S)-(+)-ar-turmerone (2) [6]. 
 
 
 
  
 
 
Previous investigations showed that xanthorrhizol (1) possessed various 
bioactivities. Aguilar et al. reported that (1) possessed antifungal activity against 
Candida albicans, toxicity against Artemia salina and cytotoxicity against human 
nasopharyngeal carcinoma cell line  [5]. This sesquiterpenoid has been shown to 
inhibit contractions in rat uterus [7], and induced endothelium-independent 
relaxation of rat thoracic aorta [8]. Itokawa et al. reported that xanthorrhizol (1) 
showed antitumour properties [9]. Xanthorrhizol (1) was also found to show an 
antibacterial activity against Streptococcus mutans [10]. Further investigation on 
antibacterial activity of xanthorrhizol showed that this compound exhibited the 
highest antibacterial activity against Streptococcus sp. causing dental caries. These 
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results suggest that xanthorrhizol (1) can be formulated for food and dental products 
for preventing oral diseases [11]. 
 
 Four bisabolane sesquiterpenes, ar-curcumene (3), ar-turmerone (4), β-
atlantone (5) and xanthorrhizol (1) were isolated as antitumour constituents from the 
methanolic extract of the rhizomes of C. xanthorrhiza [9]. 
 
 
 
 
 
A low melting point colourless needles compound has been isolated from the 
methanol extract of C. xanthorrhiza, which was identified as germacrone (6). This 
compound showed hypothermic effect to mice [12] and anti-inflammatory action 
[13]. 
 
 
 
 
Uehara et al. isolated three new bisabolane sesquiterpenenoids, namely 
bisacurone (7), bisacumol (8), and bisacurol (9) from chloroform-soluble fractions of 
the rhizomes of C. xanthorrhiza. Besides that, one known compound, curlone (10) 
was also isolated in this investigation. Spectroscopy, chemical conversion and CD 
exciton chirality have been employed in determining the absolute structures of these 
new compounds [14].  
 
 
 
 
 
Further investigation of the chloroform-soluble fractions of the rhizomes of 
C. xanthorrhiza by the same group afforded four new bisacurone related compounds, 
namely bisacurone epoxide (11), bisacurone A (12), bisacurone B (13) and 
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bisacurone C (14). Compound (11) was converted to its monoacetate to determine its 
relative stereostructure by X-ray crystallography [15]. 
 
 
 
 
 
In the course of investigating terpenoids and curcuminoids in the fresh 
rhizomes of C. xanthorrhiza, Uehara et al. isolated nine sesquiterpenoids, 
xanthorrhizol (1), ar-curcumene (3), ar-turmerone (4), germacrone (6), β-curcumene 
(15), β-sesquiphellandrene (16), curzerenone (17) and α-turmerone (18) [16]. 
 
 
 
 
 
In 1993, Pandji and co-workers investigated the insecticidal constituents from 
four species of Zingiberaceae, including C. xanthorrhiza. In this study, 
furanodienone (19) was isolated from the rhizomes [17]. Another closely related 
sesquiterpenoids, furanodiene (20) was isolated from the rhizomes of Malaysian C. 
xanthorrhiza [18]. 
 
 
 
 
 
 Besides sesquiterpenoids, diarylheptanoids have also been found abundant in 
the rhizomes of C. xanthorrhiza. Three major diarylheptanoids, curcumin (21), 
demethoxycurcumin (22) and bisdemethoxycurcumin (23) have been isolated from 
the rhizomes of this species [19]. 
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These three curcuminoids was also isolated from turmeric (Curcuma longa 
Linn.). The yellow pigment of C. xanthorrhiza and other Curcuma sp., curcumin was 
isolated as early as 1815 [20] and in 1870, Daube isolated it in crystalline form [21]. 
The structure of curcumin was elucidated in 1910 by Lampe and co-workers [22] and 
synthesised by the same group in 1918 [23]. Roughley studied the biosynthesis of 
curcumin and completed the synthesis of curcumin in 1973 [24].  
 
Curcumin shows a variety of pharmacological effects. Among others, 
curcumin is an antioxidant agent, showed radical-scavenging antioxidant activity 
against lipid peroxidation in various media, and suppressed free-radical-induced 
oxidation of methyl linoleate in solutions and aqueous emulsion. Curcumin is 
comparable to isoeugenol as an antioxidant [25]. 
 
Curcumin has also been reported to possess anti-inflammatory properties [26, 
27] and inhibits platelet aggregation [28]. Curcumins (21-23) have been shown to 
possess antiprotozoal activities against Plasmodium falciparum and Leishmania 
major [29]. Recently, Eun-kyoung Song et al. reported that compounds (21-23) 
showed free radical scavenging effects and showed significant hepatoprotective 
effects on tacrine-induced cytotoxicity in human liver-derived Hep G2 Cells [30].  
 
Uehara et al. have isolated two new diarylheptanoids, octahydrocurcumin 
[(3S,5S)-1,7-bis(4-hydroxy-3-methoxyphenyl)-heptane-3,5-diol] (24) and 1-hydroxy-
1,7-bis(4-hydroxy-3-methoxyphenyl)-6-heptene-3,5-one (25) and two known 
diarylheptanoids dihydrocurcumin (26) and hexahydrocurcumin (27) from methanol 
extract of C. xanthorrhiza [31]. 
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Masuda et al. isolated another curcuminoid from the acetone extract of C. 
xanthorrhiza rhizomes. Its structure has been assigned as 1-(4-hydroxy-3,5-
dimethoxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)-(1E,6E)-1,6-heptadiene-3,4-
dione (28) based on its spectral data. 
 
 
 
 
 
Compound (28) showed potent antioxidant activity against autooxidation of 
linoleic acid in a water-alcohol system and it showed slightly stronger antioxidant 
efficiency than curcumin (21) [19]. 
 
Bioassay-guided fractionation of hexane extract of this species has yielded 
three non-phenolic diarylheptanoids, identified as trans,trans-1,7-diphenyl-1,3-
heptadien-5-one (alnustone) (29), trans-1,7-diphenyl-1-hepten-5-ol (30) and 
trans,trans-1,7-diphenyl-1,3-heptadien-5-ol (31). Compound (31) was reported for 
the first time as a plant constituent. Besides that, cinnamaldehyde (32) has also been 
isolated and identified. All the three non-phenolic diarylheptanoids showed 
significant anti-inflammatory activity in the assay of carragenin-induced hind paw 
edema in rats [32]. 
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Suksamaran et al. isolated two new phenolic diarylheptanoids from the 
ethanolic extract of C. xanthorrhiza cultivated in Thailand. These two compounds 
have been identified as 5-hydroxy-7-(4-hydroxyphenyl)-1-phenyl-(1E)-1-heptene 
(33) and 7-(3,4-dihydroxyphenyl)-5-hydroxy-1-phenyl-(1E)-1-heptene (34) [2]. 
 
 
 
 
 
 
 
1.4 Syntheses of Xanthorrhizol (1) 
 
Xanthorrhizol (1) has been found to show many useful bioactivities and as a 
result, intense synthetic efforts have been directed towards the synthesis of 
xanthorrhizol (1) since the first isolation of this compound by Rimpler et al. from 
rhizomes of C. xanthorrhiza Roxb. [3]. To the best of our knowledge, nine syntheses 
have been reported for the syntheses of xanthorrhizol (1). Four syntheses of the 
racemate [33-37], three syntheses of S-(+)-xanthorrhizol (35) [6, 38-39] and two 
syntheses of R-(–)-xanthorrhizol (1) [40-41] have been reported. The syntheses 
leading to nonracemic material is the conversion of (+)-ar-turmerone (4) into S-(+)-
xanthorrhizol (35) [6] and the conversion of (–)-parvifoline (36) into (–)-
xanthorrhizol (1). Meyers [38] and Fuganti [39] completed the asymmetric total 
synthesis of S-(+)-(35). In 1999, enantiocontrolled total synthesis of R-(–)-
xanthorrhizol (1) has been completed by Sato et al. [41]. 
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1.4.1 Rane’s Short Synthesis of Xanthorrhizol (1) [35] 
 
The Rane’s synthesis of xanthorrhizol (1) started with Reformatsky reaction 
of 3-methoxy-4-methylacetophenone (37) with ethyl 4-bromocrotonate (38) to give 
ethyl 5-hydroxy-(3-methoxy-4-methylphenyl)-2-hexenoate (39) followed by 
hydrogenation over Pd-C in the presence of acetic acid to form ethyl 5-(3-methoxy-
4-methylphenyl)hexanoate (40) in high yield. Grignard reaction and iodine 
dehydration furnished xanthorrhizol methyl ether (42) as shown in Scheme 1.1. A 
short synthesis (four-steps) of xanthorrhizol methyl ether (42) has been achieved 
compared to the ten-step earlier synthesis [33]. 
 
MeO O
OEtBr
O MeO
CO2Et
OH
MeO
CO2Et
MeO
OH
RO
(37) (38) (39)
(40) (41) (42) R = Me
Zn dust
cyclohexane
reflux
1 h
H2, 10% Pd-C
EtOH-AcOH
MeMgI
Et2O
rt
6 h
I2
Benzene
10 h
(1) R = H
MeMgI
Xylene, 140 oC  
Scheme 1.1: Rane’s synthesis of xanthorrhizol (1). 
 
 
 
1.4.2 Meyers’ Asymmetric Synthesis of S-(+)-Xanthorrhizol (35) [38] 
 
In 1997, Meyers and Stoianova reported the asymmetric synthesis of  
S-(+)-xanthorrhizol (35) which is summarised in Scheme 1.2. The key chiral 
oxazoline (47) was prepared in three steps from crotonic acid (43). First, crotonic 
acid (43) was treated with ClCO2Et to furnish the mixed anhydride (44), then the 
resulting mixed anhydride (44) was reacted with t-leucinol (45) to form amide (46). 
Cyclisation of the resulting amide (46) with SOCl2 gave oxazoline (47) in 54% yield. 
Stereoselective addition of (o-methoxy-p-tolyl)lithium (48) to the chiral α,β-
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unsaturated oxazolines (47) gave compound (49). Analysis of the chromatographed 
addition products (49) revealed that the diastereomeric ratio was at least 97:3. 
Alcohol (50) was obtained by acid hydrolysis, acetylation and reduction of oxazoline 
derivative (49). Alcohol (50) was then treated with 1,2-bis(diphenylphosphino)- 
ethane tetrabromide (DIPHOSBr) (51) to yield the bromide (52). Treatment of 
bromide (52) with (2,2-dimethylvinyl)lithium gave xanthorrhizol methyl ether (42) 
in high yield (94%) and cleavage of the methyl ether (42) using sodium 
ethanethiolate in DMF gave S-(+)-xanthorrhizol (35). 
 
COOH
N
O MeO LiBr
MeO N
O MeO OH
THF
-78 oC
1. TFA, rt, 24h
2. py, Ac2O, rt, 24h
3. LiAlH4, THF
DIPHOSBr (51)
0 oC to rt
30 min
MeO Br
MeOMe2C=CHLi
THF
EtSNa
DMF
HO
(43)
(47)(54%) (48)
(49)
(50)(57%)
(52)(91%) (42)(94%)
(35)(92%)
S
(44)
O OEt
O O
ClCO2Et, Et3N H2N
HO
(S)-t-leucinol
(45)
(46)
N
H
O SOCl2
Br2Ph2P PPh2Br2
DIPHOSBr (51)
dr >97:3
OH
Scheme 1.2: Meyers’ asymmetric synthesis of S-(+)-xanthorrhizol (35). 
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1.4.3 Fuganti’s Baker’s Yeast-mediated Enantioselective Synthesis of             
            S-(+)-Xanthorrhizol (35) [39] 
 
The most recent total synthesis of xanthorrhizol (1) came from the Fuganti’s 
group as shown in Scheme 1.3 [39]. In their synthesis, the aromatic ring (56) was 
constructed by benzanullation of the hexadienoic acid derivative (55). Compound 
(55) was submitted to cyclisation using ethyl chlorochromate and triethylamine as 
base, followed by treatment with KOH to give the acid (56), which was then 
converted to benzophenone (57) in good yield by a number of straightforward 
synthetic steps. The ester (58) was synthesised from the substituted acetophenone 
(57) by Horner-Wadsworth-Emmons reaction with triethyl phosphonoacetate (ethyl 
diethoxyphosphosphorylacetate) and sodium hydride.  
 
The key step in this synthesis was Baker’s yeast-mediated enantioselective 
conversion of the unsaturated aldehyde (59) into the saturated alcohol (60). The 
result of the reduction showed a high conversion of the aldehyde (59) into the 
saturated S-(+)-alcohol (60) (49% isolated yield) and gave good enantioselectivity 
with enantiomeric excess >98%. To this end, the enantiopure alcohol (60) was 
converted into the iodide (61) via the tosyl ester derivatives and substitution with 
sodium iodide in acetone. The coupling of the iodide (61) with the Grignard reagent 
(62) catalysed by copper(I) iodide furnished enantiopure (42). Demethylation of 
compound (42) using sodium ethanethiolate in DMF afforded (S)-(+)-xanthorrhizol 
(35)  
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Ph3P COOEt
COOH
COOEt
COOH
Benzene
reflux
74%
ClCO2Et, Et3N,
THF
then aq. KOH,
reflux, 86%(53) (54) (55)
COOH
OH
(56)
1. Me2SO4, K2CO3, acetone
2. LiAlH4, THF
3. MnO2, CHCl3, reflux
4. MeMgCl, THF, 0 oC
5. MnO2, CHCl3, reflux
               73% OMe
(EtO)2POCH2CO2Et,
NaH
 81%
(57)
OMe
COOEt
(58)
1. LiAlH4, THF
2. MnO2, CHCl3, reflux
              81%
OMe
O
Baker's yeast, 
4-6 days
 49%
(59)
OMe
OH
(60)
ee > 98%
1. TsCl, Py, CH2Cl2
2. NaI, acetone, reflux
              84%
OMe
I
MgBr
CuI cat., THF
        85%(61)
(62)
O
OMe
(42)
NaSEt, DMF, reflux
            90%
OH
(35)  
Scheme 1.3: Fuganti’s Baker’s yeast-mediated enantiosynthesis of  
S-(+)-xanthorrhizol (35). 
 
 
 
1.4.4 Conversion of Parvifoline (36) to R-(–)-Xanthorrhizol (1) [40] 
 
Parvifoline (36) is a benzocyclooctene originally isolated from Cereopsis 
parvifolia [42]. It was also found in Pereziae alamani var. oolepsis [43], P. 
carpholepis [44] and P. longifolia [45].  
 
Garcia and co-workers have converted parvifoline (36) to xanthorrhizol (1) in 
five steps, as shown in Scheme 1.4. The first step was acid catalysed isomerisation of 
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parvifoline (36) to isoparvifoline (63). Ozonolysis of isoparvifoline (63) produced 
aldehyde (64). Aldehyde (64) was decarbonylated with Wilkinson’s reagent (chloro-
tris-(triphenylphosphine)rhodium) (65) to give 5-(2’-ketoheptan-6’-yl)-2-
methylphenol (66). Reactions of this intermediate with CH3MgI followed by 
dehydration yielded R-(–)-xanthorrhizol (1). This was the first synthesis of 
xanthorrhizol (1) with R-configuration. 
 
HO HOp-TsOH
C6H6
reflux
CHO
OH O
O3
(Ph3P)3RhCl (65), N2
50 oC, 3 h
OH O
MeMgI (2.2 eq.)
OH OH
OH
I2
(36) (63)
(64)
(66) (67)
(1)  
 
Scheme 1.4: Conversion of parvifoline (36) to R-(–)-xanthorrhizol (1). 
 
 
 
1.4.5 Shishido’s Enantiocontrolled Total Synthesis of R-(–)-Xanthorrhizol (1) 
 
The Shishido group has published an efficient and enantiocontrolled total 
synthesis of R-(–)-xanthorrhizol (1) [41]. This synthesis started with Heck reaction 
between 4-iodo-2-methoxytoluene (68) and 2-tert-butyl-4,7-dihydro-1,3-dioxepine 
(69) to form coupled product (70). Product (70) was submitted to ozonolysis 
followed by reductive workup with sodium borohydride (NaBH4) to give the σ-
symmetrical prochiral 2-aryl-1,3-propanediol (71). Prochiral diol (71) was subjected 
to asymmetric acetylation utilizing Candida antacrtica lipase (CAL) with vinyl 
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acetate as an acyl donor to afford an optically active monoacetate S-(72) with 94% 
ee. On the other hand, PPL-catalysed acetylation of (71) in ether yielded the desired 
monoacetate R-(72) with 83% ee in 95% yield.  The R-monoacetate was then 
tosylated and reductively deoxygenated with NaBH4 in hot DMSO to produce the S-
alcohol (74) in 65% yield in two steps. The monoacetate S-(72) was successfully 
converted to S-(74) via a five-step sequence of reactions. Methoxymethylation of S-
(72) followed by alkaline hydrolysis gave (73). Compound (73) was submitted to 
tosylation, reductive deoxygenation and acidic hydrolysis to provide S-alcohol (74). 
Then, S-alcohol (74) was transformed into sulphone (75) in two steps reaction. 
Prenylation of (75) was accomplished by treatment of (75) with n-butyllithium 
followed by prenyl bromide to afford phenylsulphonate (76). Reductive removal of 
the benzenesulphonyl group in (76) was achieved by treating with 5% sodium 
amalgam in buffered methanol to give O-methylxanthorrhizol (42). L-Selectride® 
(Lithium tri-sec-butylborohydride) (77) was used in this final step of the synthesis to 
cleave the methyl functionality of compound (42) to produce R-(–)-xanthorrhizol (1), 
the naturally occurring xanthorrhizol.  
 
The strength of this synthesis lies in the utilisation of lipase-mediated 
chemoenzymatic transformation to construct benzylic tertiary stereogenic centre. The 
convergent strategy to obtain R-alcohol (74) is also noteworthy. Scheme 1.5 
summarised the sequence of the synthetic methodology.  
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O
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3
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Scheme 1.5: Shishido’s enantiocontrolled total synthesis of (–)-xanthorrhizol (1).  
  
Reagents & Conditions: (i) 2-tert-butyl-4,7-dihydro-1,3-dioxepine (69), Pd(OAc)2, 
Ph3P, i-Pr2NEt, DMF, 80 °C, 75%; (ii) O3, CH2Cl2, MeOH (1:1), -78 °C then NaBH4, 
rt, 63%; (iii) CAL, vinyl acetate, Et2O, rt, 19%; (iv) MOMCl, i-Pr2NEt, 4-DMAP, 
CH2Cl2, rt, 81%; (v) LiAlH4, THF, rt; (vi)TsCl, Et3N, 4-DMAP, CH2Cl2, rt; (vii) 
NaBH4, DMSO, 60 °C, 72% (3 steps) for the MOM ether (74), 65% (2 steps) for R-
73; (viii) 10% HCl (aq.), MeOH, rt, 95%; (ix) PPL, vinyl acetate, Et2O, 39 °C, 95%; 
(x) nBu3P, prenyl bromide, HMPA, Ph2S, pyridine, rt, 84%; (xi) MCPBA, KHCO3, 
CH2Cl2, rt, 100%; (xii) n-BuLi, prenyl bromide, HMPA, THF, -78 °C, 82%; (xiii) 
Na-Hg, Na2HPO4, MeOH, rt, 83%; (xiv) L-Selectride® (77), THF, reflux, 78%. 
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1.5  The Sharpless Asymmetric Dihydroxylation 
 
 The cis dihydroxylation of olefins mediated by osmium tetroxide represents 
an important general method for olefin functionalisation [46]. The original 
dihydroxylation used stoichiometric amounts of OsO4, which is expensive, volatile, 
and toxic. Over the years, the original dihydroxylation procedure has been modified 
to operate the use of OsO4 in catalytic amounts, more rapid and better yield, this has 
been achieved by Sharpless [47-50]. 
 
 In Sharpless asymmetric dihydroxylation (AD), the source of asymmetric is a 
chiral amine, which forms a complex with OsO4. In 1980, Sharpless used pyridine 
(81), derived from menthol, induced ee’s of 3-18% in the dihydroxylation of trans-
stilbene (78), as shown in Scheme 1.6. Nevertheless, the reaction had to be improved 
because the ee’s were too low. In the same paper, Sharpless disclosed that 
dihydroxylation of olefins in the presence of dihydroquinidine acetate (82) or 
dihydroquinine acetate (83) under stoichiometric conditions gave optically active 
diols with 25-94% ee after hydrolysis. Cost considerations make this stoichiometric 
osmylation uneconomical [51]. Breakthrough was made in 1987 when Sharpless and 
co-workers discovered that the stoichiometric process become catalytic when N-
methylmorpholine-N-oxide (NMO) (84) was used as the co-oxidant in the 
dihydroxylation. In this landmark paper, dihydroquinidine p-chlorobenzoate (85) and 
dihydroquinine-p-chlorobenzoate (86) also were introduced as new chiral ligands 
with improved enantioselective properties. The communication described the 
catalytic AD of trans-stilbene (78) with 0.2 mol% of OsO4, 0.134 eq. of chiral 
auxiliary, and 1.2 eq. of NMO (84) as oxidant to give (R,R)-(+)-dihydrobenzoin (79) 
in 80% yield with 88% ee [52].  
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Scheme 1.6: The first enentioselective dihydroxylation reactions developed by  
                     Sharpless. 
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 Since then, four substantial improvements were made to the AD: (a) change 
of the stoichiometric oxidant from NMO to K3Fe(CN)6-K2CO3, (b) method for 
effecting increase in the rate of reaction, (c) new class of “dimeric” ligand combining 
two alkaloid units linked by an aromatic “spacer” unit, (d) a more convenient source 
of osmium(VIII). 
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 The catalytic cycle for the Sharpless AD with NMO (84) as a co-oxidant is 
shown in Scheme 1.7. The enantiomeric excess decreased when changing from 
stoichiometric to catalytic conditions. The reason for this phenomenon is due to a 
second catalytic cycle in which the chiral ligand is not involved [53]. The 
osmium(VIII) trioxoglycolate (88) has access to a secondary reaction cycle, forming 
a bisglycolate (89), hydrolysis of the glycolate give racemic diol [54]. However, 
when the catalytic system K3Fe(CN)6-K2CO3 in t-BuOH-H2O is used [55], the 
oxidant is confined to the aqueous phase, allowing the osmium(VI) glycolate (87) to 
hydrolyse in the organic phase before being reoxidised. 
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O
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O O
R
R
L
Os
O
O
O
L
O
R
R
HO
R
OH
R
R
R
HO
R
OH
R
R
R
Os
O
OO
O O
R
R
R
R
L
H2O
NMO NMM
L
(87) (88)
H2O L
(89)
Primary cycle 
(high enantioselectivity)
Secondary cycle 
(low enantioselectivity)
L = chiral ligand
NMM = 4-methyl
morpholine
 
Scheme 1.7: The two catalytic cycles for the Sharpless AD with NMO as a  
                      co-oxidant. 
 
 Slow reaction of trisubstituted olefins is due to the slow hydrolysis of the 
osmium glycolate. However, this hydrolysis can be accelerated by addition of 
methane sulphonamide. The reaction time can be as much as 50 times shorter in the 
presence of this additive [56].  
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Until 1996, over 500 different ligands have been tested and a list of the most 
useful ligands can be subsequently be drawn (Figure 1.1). Among these the PHAL 
(phthalazine) ligands (90,91) are the most widely used in the AD due to their large 
substrate applicability and are currently employed in the AD-mix formulations [56]. 
The analogs of PHAL ligands, bis-cinchona alkaloid ligands with a diphenyl 
pyrazinopyridazine spacer (DPP) (94,95) and a diphenyl phthalazine spacer (DP-
PHAL) (96,97) are also found to give excellent enantioselectivities in the AD of 
olefins. The enantioselectivies using these ligands are generally greater than or 
equivalent to those of ligands (90,91) [57]. The diphenylpyrimidine (PYR) (92,93) 
class is usually suitable for sterically congested olefins (especially terminal olefins) 
[58]. In 1996, anthraquinone (AQN) ligands (98,99) were introduced. The 
anthraquinone-based ligands lead to excellent results in the AD reactions of 
allylically substituted terminal olefins. These ligands give superior enantioselectivity 
in the AD of almost all olefins having only aliphatic substituents [59].  
 
Finally, osmium tetroxide has been replaced by non-volatile osmium source, 
potassium osmate(VI) dihydrate [K2OsO2(OH)4]. Until this point, all of the 
ingredients in the AD are solids and an AD-mix formulation of the standard reactants 
has been developed. These “AD-mixes” can be readily prepared, and there are also 
commercially available as AD-mix-α [(DHQ)2PHAL] and AD-mix-β 
[(DHQD)2PHAL]. The contents in 1kg of AD-mix are as follows: K3Fe(CN)6, 
699.6g; K2CO3, 293.9g; (DHQD)2- or (DHQ)2-PHAL, 5.52g; and K2OsO2(OH)4, 
1.04g (Figure 1.1). AD procedure needs 1.4g of this AD-mix per millimole of olefin. 
The solvent used for the reaction is a 1:1 mixture of t-BuOH and water. The solvent 
mixture separates into two liquid phases upon addition of the inorganic reagents. The 
catalytic cycle for AD under this condition is shown in Scheme 1.8.  
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Figure 1.1: Structure of phthalazine (90,91), pyrimidine (92,93),   
                   diphenylpyrazinopyridazine (DPP) (94,95), diphenylphthalazine (DP-     
                   PHAL) (96,97) and anthraquinone (AQN) (98,99) ligands used in the  
                   Sharpless AD and composition of AD-mix-α and AD-mix-β. 
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Scheme 1.8: Catalytic cycle for asymmetric dihydroxylation using potassium   
                     ferricyanide as co-oxidant.   
 
 First, osmylation of the olefin proceeds to form the osmium(VI) glycolate-
amine complex (87). Formation of (87) is presumed to occur in the organic phase in 
which all the involved species are soluble. Next, at the organic-aqueous interface, 
hydrolysis of the glycolate ester releases the diol into the organic phase and the 
reduced osmium as the hydrated osmate(VI) dianion into the aqueous phase. 
Oxidation of osmate(VI) by potassium ferricyanide regenerates osmium tetroxide via 
an intermediate perosmate(VIII) ion gives osmium tetroxide, which then migrates 
back into the organic phase to restart the cycle.   
 
 Sharpless AD is a type of ligand-accelerated catalysis because the addition of 
bis-cinchona ligand increases the reaction rate of this catalytic transformation. The 
principle of ligand acceleration is illustrated in Scheme 1.9 for the AD reaction [60].  
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Scheme 1.9: The osmylation of olefins. 
 
 Scheme 1.10 presents a mnemonic showing olefin orientation and face 
selectivity. In the mnemonic, the olefin is oriented to fit the size constraints, where 
RL = largest substituent, RM = medium-sized substituent, and RS = smallest 
substituent other than hydrogen. The oxygens will then be delivered from the upper 
face if dihydroquinidine (DHQD) derived chiral auxiliary is used and from the lower 
face if a dihydroquinine (DHQ) derived auxiliary is used.  
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Scheme 1.10: Mnemonic device for the AD of olefins. 
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1.5.1 Recent Developments in Asymmetric Dihydroxylation 
 
Mehltretter et al. demonstrated that the dihydroxylation in the presence of 
osmium tetroxide is largely pH dependent. It was found that the reaction rates for 
1,2-di-, tri-, and tetrasubstituted olefins improved at a constant pH of 12.0. In 
addition, the enantioselectivity of terminal olefins at room temperature is slightly 
enhanced by using a constant pH of 10 [61].  
 
The most widely used co-oxidant for the Sharpless AD is K3Fe(CN)6 and 
another widely used reoxidant is NMO (84). Besides that, reports on the utilisation of 
oxygen-based reoxidants such as air, O2 and H2O2 have also been published. 
Bäckvall and co-workers developed a H2O2 reoxidation process for Os(VI) by using 
NMO (84) together with flavin (100) as co-catalysts in the presence of hydrogen 
peroxide [62]. Krief et al. successfully designed a reaction system consisting of 
oxygen, catalytic amount of OsO4, (DHQD)2PHAL (91) and selenides for the 
dihydroxylation of α-methylstyrene (101) under irradiation with visible light [63].  
 
 
 
 
 
 
Döbler et al. reported the osmium-catalysed dihydroxylation of aliphatic and 
aromatic olefins using molecular oxygen or air as the stoichiometric oxidant, but the 
enentioselectivities are occur lower than those of the classical K3Fe(CN)6 co-oxidant 
system [64]. Mehltretter and co-workers developed a procedure for the 
dihydroxylation of olefins using bleach (NaClO) as the terminal oxidant. Olefins 
give the optically active diols in the presence of chiral ligand with good to excellent 
chemo- and enantioselectivities under optimised pH conditions. This new protocol 
has distinct advantages. Compared to the dihydroxylation using hydrogen peroxide 
as oxidant, the procedure has the advantage that no co-catalyst (flavin, NMO) need to 
be added. Compared to the dihydroxylation using dioxygen this procedure is faster 
and easier to perform [65]. Sodium chlorite (NaClO2) is the most recently reported 
reoxidant in Sharpless AD. Enantioselectivities of the NaClO2 AD-process are 
N
N
N
N
H
Et
Me
Me
O
O
(100) (101)
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comparable with the enantioselectivities of other AD-processes and the yields are 
good [66].  
 
 
 
1.5.2 Synthetic Application for 1,2-diols 
 
If the syn-1,2-diol is not the final functionality required, manipulation of the 
starting chiral compound can be performed. The first convenient approach is the 
conversion of diols into acetoxy halides and conversion into epoxides. The second 
method is the regioselective conversion of one of the hydroxyl group into sulphonate 
ester.  
 
 
 
1.5.2.1 Conversion of Diols into Halohydrin Esters and Epoxides 
 
1,2-Diols (102) are converted in excellent yields to acetoxychlorides or 
acetoxybromides (105,106) via acetoxonium ion intermediate (104), as shown in 
Scheme 1.11.  
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Scheme 1.11: Formation of acetoxy halides and epoxides via cyclic acetoxonium  
                       ions (104).  
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The cyclic orthoacetate (103) is prepared by acid-catalysed [pyridinium 4-
toluenesulphonate (PPTS)] transesterification of diol (102) with a slight excess of 
trimethyl orthoacetate. The cyclic orthoacetate (103) is then treated with Me3SiCl, 
acetyl chloride or acetyl bromide to form acetoxyhalides (105,106).  The formation 
of acetoxyhalides (105,106) proceed through nucleophilic attack on an intermediate 
1,3-dioxolan-2-ylium cation (104) with inversion of configuration. Treatment of the 
acetoxy halides (105) and (106) under mildly alkaline conditions [K2CO3 or 
Ambelite IRA 410 (OH-)] affords epoxide (107) in ca. 90% yield. Since both steps 
can be performed in the same reaction vessel, this reaction sequence provides an 
extremely efficient method for the direct conversion of 1,2-diols into epoxides with 
overall retention of configuration [67]. 
 
 
 
1.5.2.2 Regioselective Sulphonylation 
 
The primary OH group of a diol derived from a terminal olefin can be readily 
converted to a sulphonate leaving group by treating with arenesulphonyl chloride in 
the presence of tertiary amine. Under alkaline conditions, hydroxysulphonates are 
converted to chiral epoxide. The olefin → diol → monosulphonate → epoxide 
reaction sequence has been applied in a number of natural product and drug 
syntheses. An example for the usefulness of this sequence is shown in Scheme 1.12. 
3-(1,2-Dihydroxyethyl)-1,5-dihydro-3H-2,4-benzodioxepine (108), a protected 
glyceralaldehyde can be obtained in good enantiomeric excess by the 
dihydroxylation of the corresponding acrolein acetal and recrystallization from 
benzene. Monotosylation, followed by treatment with sodium methoxide gives 
glyceraldehydes building block (110) [68]. 
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Scheme 1.12: Synthesis of glyceraldehyde building block (110). 
 
 
 
1.6 Application of Sharpless AD on the Synthesis of Natural Products 
 
1.6.1 Sharpless’s Asymmetric Synthesis of the C-13 Side Chain (115) of Taxol 
 
 Since the publication by Sharpless in 1992 [56], more researchers have been 
using the AD in syntheses, including synthesis of natural products. One of the 
examples was the Sharpless’s asymmetric synthesis of taxol C-13 side chain, as 
shown in Scheme 1.13. Sharpless AD on the methyl cinnamate (111) furnishes the 
diol (112) in 72% yield and 99% ee after recrystallisation. The original secondary 
oxidant, NMO (84) was used as the co-oxidant instead of K3Fe(CN)6. This allows the 
reaction to be run at a very high concentration (2M). The diol (112) was converted to 
the acetoxybromoester (113) by reaction with trimethyl orthoacetate in the presence 
of a catalytic amount of p-TsOH, followed by treatment with acetyl bromide. The 
latter step was regioselective (6:1 mixture of the two acetoxybromo esters) favouring 
the desired product.  
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Scheme 1.13: Sharpless’s asymmetric synthesis of the C-13 side chain (115) of taxol   
(116). 
 
The acetoxybromo ester (113) was converted to N-acetyl-3-phenylisoserine 
(114) through displacement of the bromide with azide, followed by hydrogenation of 
the azide to the amine and trans-acylation to afford acetamide (114). Hydrolysis of 
the acetamide, benzoylation, and hydrolysis of the ester then gives the C-13 side 
chain (115) of taxol (116) in 23% overall yield from methyl cinnamate (111) [69].  
 
 
 
1.6.2 Corey’s Total Synthesis of (–)-Ovalicin (117) 
 
Inhibition of angiogenesis, the process of development of new blood vessel, 
is a potentially valuable medical strategy to prevent the growth of solid tumours by 
cutting off their blood supply. Ovalicin (117) inhibits angiogenesis has prompted 
Corey and co-workers to resynthesise ovalicin (117), which has been previously 
prepared as racemate [70], as shown in Scheme 1.14,  
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Scheme 1.14: Corey’s total synthesis of (–)-ovalicin (117). 
 
  Direct AD of (118) with (DHQ)2PHAL as the chiral ligand gives (119) in 
only 18% ee. However, AD of the p-methoxybenzyl ether (120) affords (121) in 93% 
yield and the ee was dramatically increased to more than 99%. This interesting result 
was attributed to attractive interactions between the PMB group and the aromatic 
units on the ligand [71]. Enantiomerically pure (121) can be converted to 
intermediate (122) and thence to (–)-ovalicin (117) by using a previously established 
pathway [70].  
 
 
 
1.6.3 Nicolaou’s Total Synthesis of Apoptolidin (123) 
 
 Apoptolidin (123) is a potent apoptolisis-inducing agent isolated from 
Nocardiopsis sp. It has been found to induce apoptotic cell death selectively in rat 
glia cells transformed with the adenovirus E1A oncogene. In addition, this 20-
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membered macrocyclic lactone has also been shown to be an inhibitor of the 
mitochondrial F0F1-ATP synthase. The interesting biological activities and novel 
structure of apoptolidin (123) prompted Nicolaou and co-workers to synthesise this 
compound (123) [72-73].  
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AD of α,β-unsaturated ketone (124) is an example of AD of electron-deficient 
olefins using a buffered AD-mix conditions. The use of buffered condition 
circumvents problems associated with epimerisation of the α-centre and/or retroaldol 
fragmentation [74-75]. AD of compound (124) with modified AD-mix-α to form the 
C19–C20 syn diol system failed, leading to an inseparable mixture (ca.1:1) of the two 
possible isomers (126) [72] (Scheme 1.15). However, simply removing the TBS 
protecting group on the C23 oxygen dramatically increases the diastereoselectivity of 
the AD to 6:1. This striking result showed that the substituent on the C23 oxygen 
exerted a strong influence on the dihydroxylation reaction. This interesting result 
also showed that the stereocontrolling factor (the group on the C23 oxygen) is situated 
four carbon away from the olefinic site where the reaction takes place.  
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Scheme 1.15: Nicolaou’s synthesis of apoptolidin (123). 
 
 
 
1.6.4 Solid-Phase Synthesis of (3’R,4’R)-Di-O-cis-acyl 3-Carbonyl 
Khellactones (131) 
 
Solid-phase synthesis of small organic molecules has emerged as an 
important technology, enabling chemists to synthesise numerous interesting 
pharmaceutical compounds [76-77]. Although Sharpless AD reactions have been 
successfully and widely used in the solution phase, AD reactions on solid phase have 
been reported only infrequently. Lee et al. used Sharpless AD as one of the key steps 
in solid-phase synthesis of substituted khellactones, as shown in Scheme 1.16. 
Substituted khellactone exhibits a broad range of biological activities, including 
antifungal, antitumour, antiviral and anti-HIV effects. The resin used in this synthesis 
was Wang resin. In the AD of the khellactone, resin (128) was subjected to Sharpless 
AD using (DHQ)2-PHAL as ligand and catalytic OsO4 to yield (129) in 99% ee. The 
acyl khellactones (130) were synthesised by acylation of the resin (129). 
Symmetrical anhydrides were prepared from the carboxylic acid using 1 equivalent 
of DIC (131) in CH2Cl2. Resin (129) was treated with excess anhydride in the 
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presence of DIEA and DMAP to furnish resin (130). The product (132) was cleaved 
from the solid support (130) by 50% trifluoroacetic acid in CH2Cl2 for 2h [78].  
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Scheme 1.16: Asymmetric solid-phase synthesis of (3’R,4’R)-di-O-cis-acyl 3-  
                        carbonyl khellactones (131).   
 
 
 
1.7 Xanthorrhizol as Chiral Starting Material for the Synthesis of Natural        
        Products 
 
 A variety of aromatic bisabolane type natural products is widely distributed, 
both in terrestrial as well as in marine organisms.  In spite of their rather simple 
structures, some of them have characteristic biological activities.  These compounds 
have attracted synthetic chemists for about 30 years.  The parent hydrocarbons (+)-
ar-curcumene (3) and dehydro-ar-curcumene (133) are the basic skeleton of aromatic 
bisabolanes found in many plant essential oils.  Examples of the phenolic aromatic 
bisabolanes are (–)-xanthorrhizol (1), allylic alcohols (134) and (135) [4, 79-80], and 
the rearranged bisabolane elvirol (136) [81]. More highly oxidised aromatic 
bisabolanes include triols (137) and (138) [82], (–)-curcuquinone (139), (–)-
curcuhydroquinone (140) [83], and gladulone A (141) [84].  
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 Although numerous syntheses of racemic phenolic bisabolane type 
sesquiterpenoids have been known, only a few stereoselective syntheses were 
reported due to the difficulty of introducing a stereogenic centre in the benzylic 
position. Besides total synthesis, an alternative way is using natural sesquiterpenoids 
as starting material for the synthesis of aromatic bisabolane sesquiterpenoids. 
However, target oriented synthesis of sesquiterpenoids starting from abundantly 
available natural sesquiterpenoids is a challenging task. It is due to the target 
molecule which is mostly just one specific molecule and the structural variety in the 
starting material is often limited. This imposes a double problem and often new or 
specific methodology has to be developed to achieve such a synthesis.  
 
 One of the potential starting materials in this method is xanthorrhizol (1), 
which is the main component in the essential oil of C. xanthorrhiza. Although the 
synthesis of xanthorrhizol (1) has been extensively studied (see Session 1.4), the 
difficulties in isolation and supply have limit the studies on the chemistry of this 
compound. To date, only one report has been published on the chemistry of 
xanthorrhizol. Aguilar et al. prepared several simple derivatives of xanthorrhizol (1), 
which displayed mild antifungic activities and did not show cytotoxic activities 
towards certain human cell lines [85]. Xanthorrhizol (1) used in this study was 
isolated from the Mexican medicinal plant, Iostephane heterophylla. Thus, it is of 
great interest to study the chemistry of xanthorrhizol (1) in order to exploit the 
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readily available of this compound as a starting material to the other useful 
compounds.  
 
 It is interesting to note that xanthorrhizol (1) is found to be a suitable starting 
material for the synthesis of several structurally related sesquiterpenoids, viz 
curcuquinone (139), curcuhydroquinone (140), allylic alcohol (134) and (135), 
helibisabonol A (142) and others as shown in Scheme 1.17.  
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Scheme 1.17: Xanthorrhizol derivatives. 
 
 Besides that, xanthorrhizol (1) is a precursor for heliannane type 
sesquiterpenoids, particularly heliannuol D (143). Shishido and co-workers have 
prepared heliannuol D (143), an allelochemical, starting from the synthetic R-(–)-
xanthorrhizol (1) as shown in Scheme 1.18 [86].  
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Scheme 1.18: Shishido’s synthesis of (+)-heliannuol D (143) from synthetic 
 (–)-xanthorrhizol (1). 
 
 The starting material, (–)-xanthorrhizol (1) was previously prepared by the 
same group (see Session 1.4.5). Xanthorrhizol (1) was subjected to sequential 
protection, Sharpless AD and bromination to furnish MOM-protected key 
intermediate (144). Treatment of (144) with palladium acetate (3 mol%) in the 
presence of rac-2-(di-tert-butylphosphino)-1,1’-binaphthyl (145) (2.5 mol%) and 
cesium carbonate in toluene at 80 °C produced the desired aryl ether (146) in 32% 
yield. Acidic hydrolysis of compound (146) with 3N HCl in THF afforded (+)-
heliannuol D (143) in 96% yield.  
 
 Heliannuol D (143) has been isolated by Macías from the moderately polar 
active fractions of the leaf aqueous extract of sunflowers (Helianthus annuus L. SH-
222). Heliannuol D (143) has been found to be a promising group of phenolic 
allelochemicals that exhibit activity against dicotyledon plant species [87].  
 
 Allelopathy is a brand of science, which studies biochemical plant-plant and 
plant-microorganism interactions. Allelopathy is most commonly defined as any 
direct or indirect effect (stimulatory or inhibitory) by one plant, including 
microorganisms, on another plant or microorganism through the production of 
chemical compounds released into the environment [88]. Allelochemicals have been 
implicated as biocommunicators and are an important potential source for new 
herbicides and agrochemicals [89]. 
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1.8 Objectives 
 
The first objective is to isolate xanthorrhizol (1) from the essential oil of C. 
xanthorrhiza by VLC purification. The second goal is to convert xanthorrhizol (1) to 
several bisabolane-type sesquiterpenoids, viz. both diastereomers of 10,11-dihydro-
10,11-dihydroxyxanthorrhizols (137,138), curcuquinone (139), curcuhydroquinone 
(140), helibisabonol A (142) and allylic alcohol derivative of O-methylxanthorrhizol 
(147), as shown in the flow chart (Figure 1.2).  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Isolation of xanthorrhizol (1) and transformation of xanthorrhizol (1)   
                    to several bisabolane type sesquiterpenoids. 
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